Missing/wrong data?
Log in to edit
Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-bas
scientific article published on May 9, 2011
Author/s
author: Kelly K Hunt, Laura Esserman, Vera J Suman, Gildy V Babiera
Work details
Publication date
May 9, 2011
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.